Objectives-To study the ability of technetium-99m hexamethyl propylene amineoxime (HMPAO) labelled lymphocyte scintigraphy to quantify synovial inflammation, and to analyse the kinetics of lymphocyte retention in the joints of patients with rheumatoid arthritis (RA). Methods-After isolation of the lymphocytes, the cells were radiolabelled in vitro with 250 MBq 9'Tc-HMPAO. The scans were performed 30 minutes, three hours and 20 hours after injection.
Rheumatoid arthritis (RA) is an autoimmune disease in which joint inflammation is mediated through helper-inducer lymphocytes. ' The retention of circulating lymphocytes in the joints is regulated by the expression of adhesion molecules, and the critical step is the ability of endothelial cells to act as an adhesive surface for migrating lymphocytes.2 Cytokines produced at the inflammatory site enhance the adhesion of leucocytes to endothelial cells by inducing the expression of endothelial leucocyte adhesion molecules, intercellular adhesion molecules (ICAM), vascular cellular adhesion molecules, and 1l-integrin expression on lymphocytes. 3'4 Initially, the T lymphocyte infiltration in the synovial membrane seems to be selective and limited, but in long standing disease, polyclonal lymphocytes accumulate within the joints without specificity. 5 6 This suggests that the joint retention of lymphocytes in RA must fluctuate with the stages of the disease.
The evaluation of inflammation in arthritic joints is a matter of subjective judgment, and therefore has poor reproducibility. An accurate assessment to detect and quantify the lymphocyte inflammation in RA is clearly needed. Different isotope tracer techniques with various biological compounds have been used to assess joint inflammation in the disease. Radiolabelled immunoglobulin scintigraphy seems to be a sensitive method to evaluate inflamed joints, without specificity. 7 In RA, indium-i1 labelled polynuclear neutrophil joint scintigraphy was reliable in acute inflammation, but false negative results were observed in patients with prolonged illness. Furthermore, the indium-111 leucocyte uptake did not clearly change between the different times of measurement, and no information on the kinetics of leucocyte accumulation in the joints was available. 8 We describe for the first time the use of technetium-99m hexamethylpropylene amineoxime (HMPAO) radiolabelled lymphocyte scintigraphy in RA.
Patients and methods

PATIENTS
Eight patients with definite RA according to the American Association Criteria were selected.9 They were six women and two men; the mean (SD) age was 63-5 (4) years. Their disease duration ranged from eight months to 22 years. Rheumatoid factor was present in six of the patients. All patients were being treated with non-steroidal anti-inflammatory drugs, and six with disease modifying anti-rheumatic drugs (three with parenteral gold, two with methotrexate and one with sulphasalazine). Synovial histology was available in three patients who had surgery after the scintigraphy. on fig 4A) . ROI on this region showed an increased count per pixel (0 44) compared with ROI of the same surface taken on the joint signal (0 3 counts/ pixel). On the same patients 20 hours after injection, this linear image disappeared but ROI on the joint region showed a persistent increased activity (0 55). In contrast, in the joints of four patients with long standing disease (eight to 22 years), a 20 hours comparable signal could be detected at 30 minutes (0d199 (0.066)), but appeared less intense at three hours (0.244 (0 055)) and decreased at 20 hours (0d129 (0-42)) as shown in figure 2B . The variation over time did not reach statistical significance within this group of patients with RA. In contrast, the signal obtained at 20 hours was different between the two groups of patients (F test = 9446, p < 0-002), and the curve obtained in the group of patients with long duration RA tended to be distinct from patients with early disease. The loss of radioactivity of the whole SCID mouse body 20 hours after injection was 36% of initial activity corrected for the half-life of technetium (range 22-45%). No significant activity was observed in control mice injected with Tc-free HMPAO.
Fifty per cent of initial activity corrected for 99MTc decay remained in human lymphocytes incubated in vitro for 20 hours. 20 In three cases, the patients had surgery after the scintigraphy, and synovial histology was available. In two patients with early onset RA, an intense mononuclear cell infiltrate was present in the synovial tissue. The joint scintigram showed an intense and early signal. In the last patient, RA persisted for 20 years, and the progression of the disease was characterised by hip joint destruction which required a total arthroplasty. A scintigram of 99mTc-diphosphonate labelled bone showed an intense signal, but radiolabelled lymphocytes demonstrated a diminution of the scintigram signal ( fig 5) . The histology showed an intense fibrosis without lymphocyte infiltration.
Discussion
Precise assessment of disease activity in RA is difficult and has poor reproducibility. Joint pain is the result of effusion, local inflammation, capsule distention, and subchondral bone destruction. Furthermore, experience of pain is influenced by socio-economic status. There is a need for an objective investigational technique which could be applied to deep joints. For the first time, we have used radiolabelled lymphocyte joint scintigraphy to detect and quantify lymphocyte infiltration in the synovial membrane. HMPAO is a chelating molt penetrates the cell membrane and cellularly. The In addition, the kinetics of lymphocyte retention in the joint seems to differ with the stage of the disease. This might be a result of the variation in the intensity and specificity of adhesion molecules expression in the synovial membrane with time. 4 Three patients in our study had surgery and synovial histology was available. In two cases, RA was of early onset and the synovial membrane was highly infiltrated by lymphocytes. The HMPAO scintigraphy showed an intense and early signal. In the last patient with destruction of the hip joint, histological analysis showed a non-specific fibrosis without lymphocyte infiltration; the 99mTc-HMPAO labelled lymphocyte scintigraphy showed a decreased signal from the hip. Thus Other isotope tracer methods have been used in RA. Joint scintigraphy with polyclonal human ssmTc-immunoglobulin was a sensitive tool to detect joint inflammation, but the specificity was low, and`smTc-IgG accumulated in non-inflamed joints.'6 17 Indium-I 1 1 has been used as an intracellular marker to assess RA inflammation.8 The majority of the labelled cells were neutrophils, and while indium-i 11 leucocyte imaging had a high predictive value for joint inflammation in RA, the method was not specific for RA."8 The radiolabelled lymphocyte scintigraphy showed a low number of false positive joints, and might predict active synovitis within the joints. To assess the specificity of the method, further studies comparing the results in RA with those from other non-rheumatoid inflammatory arthropathies are needed.
Selective immunotherapy with monoclonal antibodies is being actively developed to treat refractory RA. Targets The results of our study suggest that radiolabelled lymphocyte joint scintigraphy could detect and localise active synovitis. More studies will be required to determine the specificity of this method.
